Sartorius (OTCMKTS:SARTF) Sets New 52-Week High – What’s Next?

Sartorius (OTCMKTS:SARTFGet Free Report) shares reached a new 52-week high during trading on Tuesday . The company traded as high as $226.33 and last traded at $226.33, with a volume of 5 shares trading hands. The stock had previously closed at $225.00.

Sartorius Price Performance

The stock has a 50 day moving average of $222.51 and a 200-day moving average of $206.01. The stock has a market capitalization of $7.75 billion, a P/E ratio of 105.27 and a beta of 0.98. The company has a current ratio of 0.95, a quick ratio of 0.49 and a debt-to-equity ratio of 0.89.

About Sartorius

(Get Free Report)

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.

See Also

Receive News & Ratings for Sartorius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sartorius and related companies with MarketBeat.com's FREE daily email newsletter.